Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Jessie L-S Au

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Anatomy

Disorders

Urinary Bladder Neoplasms

Living Beings

Procedures

Concepts & Ideas

Biological Availability

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
85
Wientjes, Guillaume
23
Gan, Yuebo
8
Dalton, James
7
Jang, Seong Hoon
7
Song, SaeHeum
7
Lu, Ze
6
Millenbaugh, NJ
6
Yeh, Teng-Kuang
5
Weaver, JR
4
Chen, Danny
3
Grever, Michael
3
Jang, Seong
3
Kuh, HJ
3
Johnston, Jeffrey
3
Villalona-Calero, Miguel

Sign-in to see all Coauthors

Publications

TOP 3
Hu Guohong; Chong Robert A; Yang Qifeng; Wei Yong; Blanco Mario A; Li Feng; Reiss Michael; Au Jessie L-S; Haffty Bruce G; Kang Yibin
MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer.
Lu Ze; Tsai Max; Lu Dan; Wang Jie; Wientjes M Guillaume; Au Jessie L-S
Tumor-penetrating microparticles for intraperitoneal therapy of ovarian cancer.
Lerner Seth P; Au Jessie L-S
Risk-adapted use of intravesical chemotherapy.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Jessie L-S Au (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Hu Guohong; Chong Robert A; Yang Qifeng; Wei Yong; Blanco Mario A; Li Feng; Reiss Michael; Au Jessie L-S; Haffty Bruce G; Kang Yibin
MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer.
Cancer cell 2009;15(1):9-20.
2008: Lu Ze; Tsai Max; Lu Dan; Wang Jie; Wientjes M Guillaume; Au Jessie L-S
Tumor-penetrating microparticles for intraperitoneal therapy of ovarian cancer.
The Journal of pharmacology and experimental therapeutics 2008;327(3):673-82.
2008: Lerner Seth P; Au Jessie L-S
Risk-adapted use of intravesical chemotherapy.
BJU international 2008;102(9 Pt B):1247-53.
2008: Villalona-Calero M A; Otterson G A; Wientjes M G; Weber F; Bekaii-Saab T; Young D; Murgo A J; Jensen R; Yeh T-K; Wei Y; Zhang Y; Eng C; Grever M; Au J L-S
Noncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(11):1903-9.
2008: Shen Zancong; Shen Tong; Wientjes M Guillaume; O'Donnell Michael A; Au Jessie L-S
Intravesical treatments of bladder cancer: review.
Pharmaceutical research 2008;25(7):1500-10.
2008: Walsh Colin T; Wei Yong; Wientjes M Guillaume; Au Jessie L S
Quantitative image analysis of intra-tumoral bFGF level as a molecular marker of paclitaxel resistance.
Journal of translational medicine 2008;6():4.
2007: Tsai Max; Lu Ze; Wang Jie; Yeh Teng-Kuang; Wientjes M Guillaume; Au Jessie L-S
Effects of carrier on disposition and antitumor activity of intraperitoneal Paclitaxel.
Pharmaceutical research 2007;24(9):1691-701.
2007: Lu Dan; Wientjes M Guillaume; Lu Ze; Au Jessie L-S
Tumor priming enhances delivery and efficacy of nanomedicines.
The Journal of pharmacology and experimental therapeutics 2007;322(1):80-8.
2007: Hu Leijun; Au Jessie L-S; Wientjes M Guillaume
Computational modeling to predict effect of treatment schedule on drug delivery to prostate in humans.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(4):1278-87.
2007: Ortiz Ronnie; Au Jessie L-S; Lu Ze; Gan Yuebo; Wientjes M Guillaume
Biodegradable intraprostatic doxorubicin implants.
The AAPS journal 2007;9(2):E241-50.
2006: Wang Jie; Lu Ze; Au Jessie L-S
Protection against chemotherapy-induced alopecia.
Pharmaceutical research 2006;23(11):2505-14.
2006: Kosarek Carrie E; Hu Xiao; Couto C Guillermo; Kisseberth William C; Green Eric M; Au Jessie L S; Wientjes M Guillaume
Phase I evaluation of low-dose suramin as chemosensitizer of doxorubicin in dogs with naturally occurring cancers.
Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 2006;20(5):1172-7.
2006: Gan Yuebo; Wientjes M Guillaume; Au Jessie L-S
Expression of basic fibroblast growth factor correlates with resistance to paclitaxel in human patient tumors.
Pharmaceutical research 2006;23(6):1324-31.
2006: Chen Danny; Song Sae Heum; Wientjes M Guillaume; Yeh Teng Kuang; Zhao Liang; Villalona-Calero Miguel; Otterson Gregory A; Jensen Rhonda; Grever Michael; Murgo Anthony J; Au Jessie L-S
Nontoxic suramin as a chemosensitizer in patients: dosing nomogram development.
Pharmaceutical research 2006;23(6):1265-74.
2005: Lu Ze; Wientjes Trini S-S; Au Jessie L-S
Nontoxic suramin treatments enhance docetaxel activity in chemotherapy-pretreated non-small cell lung xenograft tumors.
Pharmaceutical research 2005;22(7):1069-78.
2005: Xin Yan; Lyness Greg; Chen Danny; Song Saeheum; Wientjes M Guillaume; Au Jessie L-S
Low dose suramin as a chemosensitizer of bladder cancer to mitomycin C.
The Journal of urology 2005;174(1):322-7.
2005: Yeh Teng Kuang; Lu Ze; Wientjes M Guillaume; Au Jessie L-S
Formulating paclitaxel in nanoparticles alters its disposition.
Pharmaceutical research 2005;22(6):867-74.
2005: Wientjes M Guillaume; Zheng Jenny H; Hu Leijun; Gan Yuebo; Au Jessie L-S
Intraprostatic chemotherapy: distribution and transport mechanisms.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(11):4204-11.
2004: Zhao Liang; Wientjes M Guillaume; Au Jessie L-S
Evaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analyses.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(23):7994-8004.
2004: Ogden Adam; Wientjes M Guillaume; Au Jessie L S
Suramin as a chemosensitizer: oral pharmacokinetics in rats.
Pharmaceutical research 2004;21(11):2058-63.
2004: Lu Ze; Yeh Teng-Kuang; Tsai Max; Au Jessie L-S; Wientjes M Guill
Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(22):7677-84.
2004: Song SaeHeum; Yu Bei; Wei Yong; Wientjes M Guillaume; Au Jessie L-S
Low-dose suramin enhanced paclitaxel activity in chemotherapy-naive and paclitaxel-pretreated human breast xenograft tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(18 Pt 1):6058-65.
2003: Jang Seong Hoon; Wientjes M Guillaume; Lu Dan; Au Jessie L S
Drug delivery and transport to solid tumors.
Pharmaceutical research 2003;20(9):1337-50.
2003: Villalona-Calero Miguel A; Wientjes M Guillaume; Otterson Gregory A; Kanter Steven; Young Donn; Murgo Anthony J; Fischer Beth; DeHoff Carrie; Chen Danny; Yeh Teng-Kuang; Song SaeHeum; Grever Michael; Au Jessie L-S
Phase I study of low-dose suramin as a chemosensitizer in patients with advanced non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(9):3303-11.
2003: Johnston Jeffrey S; Johnson Andrew; Gan Yuebo; Wientjes M Guillaume; Au Jessie L S
Synergy between 3'-azido-3'-deoxythymidine and paclitaxel in human pharynx FaDu cells.
Pharmaceutical research 2003;20(7):957-61.
2003: Mo Yiqun; Gan Yuebo; Song SaeHeum; Johnston Jeffrey; Xiao Xiaodong; Wientjes M Guillaume; Au Jessie L-S
Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
Cancer research 2003;63(3):579-85.
2003: Jang Seong Hoon; Wientjes M Guillaume; Au Jessie L-S
Interdependent effect of P-glycoprotein-mediated drug efflux and intracellular drug binding on intracellular paclitaxel pharmacokinetics: application of computational modeling.
The Journal of pharmacology and experimental therapeutics 2003;304(2):773-80.
2003: Li Dong; Jang Seong H; Kim Jonghan; Wientjes M Guillaume; Au Jessie L S
Enhanced drug-induced apoptosis associated with P-glycoprotein overexpression is specific to antimicrotubule agents.
Pharmaceutical research 2003;20(1):45-50.
2003: Chen Danny; Song Di; Wientjes M Guillaume; Au Jessie L-S
Effect of dimethyl sulfoxide on bladder tissue penetration of intravesical paclitaxel.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1):363-9.
2002: Gan Yuebo; Mo Yiqun; Johnston Jeffrey; Lu Jie; Wientjes M Guillaume; Au Jessie L-S
Telomere maintenance in telomerase-positive human ovarian SKOV-3 cells cannot be retarded by complete inhibition of telomerase.
FEBS letters 2002;527(1-3):10-4.
2002: Au Jessie L-S; Jang Seong H; Wientjes M Guill
Clinical aspects of drug delivery to tumors.
Journal of controlled release : official journal of the Controlled Release Society 2002;78(1-3):81-95.
2001: Gan Y; Engelke K J; Brown C A; Au J L
Telomere amount and length assay.
Pharmaceutical research 2001;18(12):1655-9.
2001: Li D; Gan Y; Wientjes M G; Badalament R A; Au J L
Distribution of DT-diaphorase and reduced nicotinamide adenine dinucleotide phosphate: cytochrome p450 oxidoreductase in bladder tissues and tumors.
The Journal of urology 2001;166(6):2500-5.
2001: Zhang Y; Song S; Yang F; Au J L; Wientjes M G
Nontoxic doses of suramin enhance activity of doxorubicin in prostate tumors.
The Journal of pharmacology and experimental therapeutics 2001;299(2):426-33.
2001: Jang S H; Wientjes M G; Au J L
Kinetics of P-glycoprotein-mediated efflux of paclitaxel.
The Journal of pharmacology and experimental therapeutics 2001;298(3):1236-42.
2001: Song S; Wientjes M G; Walsh C; Au J L
Nontoxic doses of suramin enhance activity of paclitaxel against lung metastases.
Cancer research 2001;61(16):6145-50.
2001: Li D; Au J L
Mdr1 transfection causes enhanced apoptosis by paclitaxel: an effect independent of drug efflux function of P-glycoprotein.
Pharmaceutical research 2001;18(7):907-13.
2001: Au J L; Jang S H; Zheng J; Chen C T; Song S; Hu L; Wientjes M G
Determinants of drug delivery and transport to solid tumors.
Journal of controlled release : official journal of the Controlled Release Society 2001;74(1-3):31-46.
2001: Gan Y; Mo Y; Kalns J E; Lu J; Danenberg K; Danenberg P; Wientjes M G; Au J L
Expression of DT-diaphorase and cytochrome P450 reductase correlates with mitomycin C activity in human bladder tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(5):1313-9.
2001: Gan Y; Lu J; Johnson A; Wientjes M G; Schuller D E; Au J L
A quantitative assay of telomerase activity.
Pharmaceutical research 2001;18(4):488-93.
2001: Au J L; Badalament R A; Wientjes M G; Young D C; Warner J A; Venema P L; Pollifrone D L; Harbrecht J D; Chin J L; Lerner S P; Miles B J;
Methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial.
Journal of the National Cancer Institute 2001;93(8):597-604.
2001: Jang S H; Wientjes M G; Au J L
Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule.
The Journal of pharmacology and experimental therapeutics 2001;296(3):1035-42.
2000: Song S; Wientjes M G; Gan Y; Au J L
Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(15):8658-63.
2000: Kuh H J; Jang S H; Wientjes M G; Au J L
Computational model of intracellular pharmacokinetics of paclitaxel.
The Journal of pharmacology and experimental therapeutics 2000;293(3):761-70.
2000: Millenbaugh N J; Wientjes M G; Au J L
A pharmacodynamic analysis method to determine the relative importance of drug concentration and treatment time on effect.
Cancer chemotherapy and pharmacology 2000;45(4):265-72.
1999: Kuh H J; Jang S H; Wientjes M G; Weaver J R; Au J L
Determinants of paclitaxel penetration and accumulation in human solid tumor.
The Journal of pharmacology and experimental therapeutics 1999;290(2):871-80.
1999: Millenbaugh N J; Wientjes M G; Au J L
Accuracy and precision of pharmacodynamic exponent.
Pharmaceutical research 1999;16(1):170-3.
1999: Knemeyer I; Wientjes M G; Au J L
Cremophor reduces paclitaxel penetration into bladder wall during intravesical treatment.
Cancer chemotherapy and pharmacology 1999;44(3):241-8.
1999: Weaver J R; Wientjes M G; Au J L
Regional heterogeneity and pharmacodynamics in human solid tumor histoculture.
Cancer chemotherapy and pharmacology 1999;44(4):335-42.
1998: Gan Y; Wientjes M G; Au J L
Relationship between paclitaxel activity and pathobiology of human solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(12):2949-55.
1998: Gan Y; Au J L; Lu J; Wientjes M G
Antiproliferative and cytotoxic effects of geldanamycin, cytochalasin E, suramin and thiacetazone in human prostate xenograft tumor histocultures.
Pharmaceutical research 1998;15(11):1760-6.
1998: Weaver J R; Gan Y; Au J L
Proliferation indices as molecular pharmacodynamic endpoints in evaluation of anticancer drug effect in human solid tumors.
Pharmaceutical research 1998;15(10):1546-51.
1998: Chen C T; Gan Y; Au J L; Wientjes M G
Androgen-dependent and -independent human prostate xenograft tumors as models for drug activity evaluation.
Cancer research 1998;58(13):2777-83.
1998: Au J L; Li D; Gan Y; Gao X; Johnson A L; Johnston J; Millenbaugh N J; Jang S H; Kuh H J; Chen C T; Wientjes M G
Pharmacodynamics of immediate and delayed effects of paclitaxel: role of slow apoptosis and intracellular drug retention.
Cancer research 1998;58(10):2141-8.
1998: Chen C T; Au J L; Wientjes M G
Pharmacodynamics of doxorubicin in human prostate tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(2):277-82.
1998: Gao X; Au J L; Badalament R A; Wientjes M G
Bladder tissue uptake of mitomycin C during intravesical therapy is linear with drug concentration in urine.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(1):139-43.
1998: Millenbaugh N J; Gan Y; Au J L
Cytostatic and apoptotic effects of paclitaxel in human ovarian tumors.
Pharmaceutical research 1998;15(1):122-7.
1998: Gan Y; Wientjes M G; Lu J; Au J L
Cytostatic and apoptotic effects of paclitaxel in human breast tumors.
Cancer chemotherapy and pharmacology 1998;42(3):177-82.
1997: Au J L; Panchal N; Li D; Gan Y
Apoptosis: a new pharmacodynamic endpoint.
Pharmaceutical research 1997;14(12):1659-71.
1997: Weaver J R; Au J L
Application of automatic thresholding in image analysis scoring of cells in human solid tumors labeled for proliferation markers.
Cytometry 1997;29(2):128-35.
1997: Song D; Wientjes M G; Gan Y; Au J L
Bladder tissue pharmacokinetics and antitumor effect of intravesical 5-fluorouridine.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(6):901-9.
1997: Kang H J; Wientjes M G; Au J L
Physiologically based pharmacokinetic models of 2',3'-dideoxyinosine.
Pharmaceutical research 1997;14(3):337-44.
1997: Yen W C; Au J L
Pharmacodynamic evaluation of mitomycin C analog BMS-181174 for potential use in intravesical bladder cancer therapy.
Pharmaceutical research 1997;14(2):241-5.
1997: Weaver J R; Au J L
Comparative scoring by visual and image analysis of cells in human solid tumors labeled for proliferation markers.
Cytometry 1997;27(2):189-99.
1997: Au J L; Kalns J; Gan Y; Wientjes M G
Pharmacologic effects of paclitaxel in human bladder tumors.
Cancer chemotherapy and pharmacology 1997;41(1):69-74.
1997: Song D; Wientjes M G; Au J L
Bladder tissue pharmacokinetics of intravesical taxol.
Cancer chemotherapy and pharmacology 1997;40(4):285-92.
1996: Yen W C; Schmittgen T; Au J L
Different pH dependency of mitomycin C activity in monolayer and three-dimensional cultures.
Pharmaceutical research 1996;13(12):1887-91.
1996: Yen W C; Wientjes M G; Au J L
Differential effect of taxol in rat primary and metastatic prostate tumors: site-dependent pharmacodynamics.
Pharmaceutical research 1996;13(9):1305-12.
1996: Gan Y; Wientjes M G; Badalament R A; Au J L
Pharmacodynamics of doxorubicin in human bladder tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(8):1275-83.
1996: Gan Y; Wientjes M G; Schuller D E; Au J L
Pharmacodynamics of taxol in human head and neck tumors.
Cancer research 1996;56(9):2086-93.
1996: Yeh T K; Kang H J; Wientjes M G; Au J L
Pharmacokinetic interaction between intravenous 2',3'-dideoxyinosine and pentamidine in rats.
Pharmaceutical research 1996;13(4):628-32.
1996: Song D; Hsu L F; Au J L
Binding of taxol to plastic and glass containers and protein under in vitro conditions.
Journal of pharmaceutical sciences 1996;85(1):29-31.
1996: Wientjes M G; Badalament R A; Au J L
Penetration of intravesical doxorubicin in human bladders.
Cancer chemotherapy and pharmacology 1996;37(6):539-46.
1995: Gao X; Wientjes M G; Au J L
Use of drug kinetics in dermis to predict in vivo blood concentration after topical application.
Pharmaceutical research 1995;12(12):2012-7.
1995: Gao X; Wientjes M G; Au J L
Extensive absorption of 2',3'-dideoxyinosine by intratracheal administration in rats.
Pharmaceutical research 1995;12(12):1901-6.
1995: Kalns J E; Millenbaugh N J; Wientjes M G; Au J L
Design and analysis of in vitro antitumor pharmacodynamic studies.
Cancer research 1995;55(22):5315-22.
1995: Wientjes M G; Pretlow T G; Badalament R A; Burgers J K; Au J L
Histocultures of human prostate tissues for pharmacologic evaluation.
The Journal of urology 1995;153(4):1299-302.
1995: Gupta E; Wientjes M G; Au J L
Penetration kinetics of 2',3'-dideoxyinosine in dermis is described by the distributed model.
Pharmaceutical research 1995;12(1):108-12.
1994: Gao X; Buffington C A; Au J L
Effect of interstitial cystitis on drug absorption from urinary bladder.
The Journal of pharmacology and experimental therapeutics 1994;271(2):818-23.
1994: Schmittgen T D; Weaver J M; Badalament R A; Wientjes M G; Klein E A; Young D C; Au J L
Correlation of human bladder tumor histoculture proliferation and sensitivity to mitomycin C with tumor pathobiology.
The Journal of urology 1994;152(5 Pt 1):1632-6.
1994: Kang H J; Wientjes M G; Au J L
Tissue pharmacokinetics of 2',3'-dideoxyinosine in rats.
Biochemical pharmacology 1994;48(11):2109-16.
1994: Chai M; Wientjes M G; Badalament R A; Burgers J K; Au J L
Pharmacokinetics of intravesical doxorubicin in superficial bladder cancer patients.
The Journal of urology 1994;152(2 Pt 1):374-8.
1994: Mukherji E; Au J L; Mathes L E
Differential antiviral activities and intracellular metabolism of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine in human cells.
Antimicrobial agents and chemotherapy 1994;38(7):1573-9.
1994: Mukherji E; Millenbaugh N J; Au J L
Percutaneous absorption of 2',3'-dideoxyinosine in rats.
Pharmaceutical research 1994;11(6):809-15.
1993: Yeh T K; Dalton J T; Au J L
High-performance liquid chromatographic determination of pentamidine in plasma.
Journal of chromatography 1993;622(2):255-61.
1993: Au J L; Wientjes M G; Rosol T J; Koolemans-Beynen A; Goebel E A; Schuller D E
Histocultures of patient head and neck tumors for pharmacodynamics studies.
Pharmaceutical research 1993;10(10):1493-9.
1993: Wientjes M G; Badalament R A; Wang R C; Hassan F; Au J L
Penetration of mitomycin C in human bladder.
Cancer research 1993;53(14):3314-20.
1993: Bramer S L; Au J L; Wientjes M G
Gastrointestinal and hepatic first-pass elimination of 2',3'-dideoxyinosine in rats.
The Journal of pharmacology and experimental therapeutics 1993;265(2):731-8.
1993: Bramer S L; Wientjes M G; Au J L
Absorption of 2',3'-dideoxyinosine from lower gastrointestinal tract in rats and kinetic evidence of different absorption rates in colon and rectum.
Pharmaceutical research 1993;10(5):763-70.
1993: Dalton J T; Au J L
2',3'-Dideoxyinosine is not metabolized in human placenta.
Drug metabolism and disposition: the biological fate of chemicals 1993;21(3):544-6.
1993: Wientjes M G; Badalament R A; Au J L
Use of pharmacologic data and computer simulations to design an efficacy trial of intravesical mitomycin C therapy for superficial bladder cancer.
Cancer chemotherapy and pharmacology 1993;32(4):255-62.
1992: Wientjes M G; Mukherji E; Au J L
Nonlinear disposition of intravenous 2',3'-dideoxyinosine in rats.
Pharmaceutical research 1992;9(8):1070-5.
1992: Wientjes M G; Au J L
Pharmacokinetics of oral 2',3'-dideoxyinosine in rats.
Pharmaceutical research 1992;9(6):822-5.
1992: Dalton J T; Harrington M D; Au J L
Evidence of significant absorption of antipyrine from urinary bladder of rats.
The Journal of pharmacology and experimental therapeutics 1992;260(2):608-13.
1992: Schmittgen T D; Koolemans-Beynen A; Webb T E; Rosol T J; Au J L
Effects of 5-fluorouracil, leucovorin, and glucarate in rat colon-tumor explants.
Cancer chemotherapy and pharmacology 1992;30(1):25-30.
1991: Dalton J T; Wientjes M G; Badalament R A; Drago J R; Au J L
Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients.
Cancer research 1991;51(19):5144-52.
1991: Wientjes M G; Dalton J T; Badalament R A; Drago J R; Au J L
Bladder wall penetration of intravesical mitomycin C in dogs.
Cancer research 1991;51(16):4347-54.
1991: Schmittgen T D; Wientjes M G; Badalament R A; Au J L
Pharmacodynamics of mitomycin C in cultured human bladder tumors.
Cancer research 1991;51(15):3849-56.
1991: Au J L; Dalton J T; Wientjes M G
Evidence of significant absorption of sodium salicylate from urinary bladder of rats.
The Journal of pharmacology and experimental therapeutics 1991;258(1):357-64.
1991: Wientjes M G; Au J L
High-performance liquid chromatographic analysis of 2',3'-dideoxyinosine in biological samples.
Journal of chromatography 1991;563(2):400-6.
1991: Wientjes M G; Dalton J T; Badalament R A; Dasani B M; Drago J R; Au J L
A method to study drug concentration-depth profiles in tissues: mitomycin C in dog bladder wall.
Pharmaceutical research 1991;8(2):168-73.
1991: Schmittgen T D; Au J L; Wientjes M G; Badalament R A; Drago J R
Cultured human bladder tumors for pharmacodynamic studies.
The Journal of urology 1991;145(1):203-7.
1989: Dalton J T; Geuns E R; Au J L
High-performance liquid chromatographic determination of mitomycin C in rat and human plasma and urine.
Journal of chromatography 1989;495():330-7.
1989: Au J L; Gunnarsson L C
Absorption of 5'-deoxy-5-fluorouridine from colon.
Pharmaceutical research 1989;6(4):323-7.
1989: Bramer S L; Gunnarsson L C; Au J L
Biologic activity of 5'-deoxy-5-fluorouridine by rectal administration.
Pharmaceutical research 1989;6(4):318-22.
1989: Au J L; Su M H; Wientjes M G
Extraction of intracellular nucleosides and nucleotides with acetonitrile.
Clinical chemistry 1989;35(1):48-51.
1988: Au J L; Wientjes M G; Bramer S L
Effect of uridine coadministration on 5'-deoxy-5-fluorouridine disposition in rats.
Cancer chemotherapy and pharmacology 1988;22(1):5-10.
1987: Au J L; Su M H; Wientjes M G
Isocratic ion-pair reversed-phase high-performance liquid chromatographic analysis of ATP and ADP.
Journal of chromatography 1987;423():308-12.
1987: Wientjes M G; Au J L
Inhibition of intestinal pyrimidine nucleoside phosphorylases.
Pharmaceutical research 1987;4(5):425-8.
1987: Au J L
Disposition and availability of 5-fluorouracil prodrug 5'-deoxy-5-fluorouridine after oral administration in rats.
Journal of pharmaceutical sciences 1987;76(9):699-702.
1987: Au J L; Rustum Y M; Slocum H K
Biological activities of 5-fluorouracil and its prodrug 5'-deoxy-5-fluorouridine in rats.
Cancer drug delivery 1987;4(3):137-44.

Sign-in to see more